Literature DB >> 2889479

Smoking and tardive dyskinesia.

R L Binder1, H Kazamatsuri, T Nishimura, D E McNiel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2889479     DOI： 10.1016/0006-3223(87)90038-2

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  5 in total

Review 1.  Hypothesis: a nicotine-dopamine interaction linking smoking with Parkinson's disease and tardive dyskinesia.

Authors:  D G Kirch; A M Alho; R J Wyatt
Journal:  Cell Mol Neurobiol       Date:  1988-09       Impact factor: 5.046

Review 2.  Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective.

Authors:  H D Desai; J Seabolt; M W Jann
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

3.  Smoking and tardive dyskinesia: lack of involvement of the CYP1A2 gene.

Authors:  Siow-Ann Chong; Ene-Choo Tan; Chay Hoon Tan
Journal:  J Psychiatry Neurosci       Date:  2003-05       Impact factor: 6.186

4.  Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories.

Authors:  Athina Markou; Paul J Kenny
Journal:  Neurotox Res       Date:  2002-06       Impact factor: 3.911

5.  Effects of chronic nicotine and haloperidol administration on muscarinic receptor-mediated phosphoinositide turnover in rat brain slices.

Authors:  R Li; L L Wing; D G Kirch; R J Wyatt; D M Chuang
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.